Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 16 de may. de 2024 · Mike Crapo (born May 20, 1951, Idaho Falls, Idaho, U.S.) is an American politician who was elected as a Republican to the U.S. Senate in 1998 and began representing Idaho the following year. He previously served in the U.S. House of Representatives (1993–99).

  2. Senator for Idaho. pronounced MĪ-kul // KRA-poh. Track Him. Contact Him. Crapo is the senior senator from Idaho and is a Republican. He has served since Jan 6, 1999. Crapo is next up for reelection in 2028 and serves until Jan 3, 2029. He is 73 years old.

  3. 2 de may. de 2024 · WASHINGTON – U.S. Senators Jim Risch (R-Idaho), ranking member of the Senate Foreign Relations Committee, and Mike Crapo (R-Idaho) yesterday joined the entire Senate Republican conference in sending a letter to President Biden calling for his administration to withdraw its support for two international agreements being considered ...

  4. Hace 6 días · Senate Finance Committee Republicans have launched working groups as part of their preparation for the 2025 tax cliff, when a swath of provisions from the 2017 tax law expires. The panel’s top Republican, Sen. Mike Crapo of Idaho, told Bloomberg Tax Thursday the groups will cover every aspect of the expiring tax breaks to prepare for next ...

  5. 17 de may. de 2024 · Scott Cleveland is a financial adviser and Ada County Republican Party official who received about 8% of the statewide vote in his independent bid against Republican U.S. Sen. Mike Crapo in...

  6. 10 de may. de 2024 · Washington, D.C. --U.S. Senator Mike Crapo (R-Idaho) joined collegeagues in introducing a Senate resolution that condemns any action by the Biden Administration to withhold or restrict weapons for Israel. The resolution is cosponsored by a total of 48 Republican senators.

  7. 17 de may. de 2024 · Washington, D.C. --U.S. Senate Finance Committee Ranking Member Mike Crapo (R-Idaho) and Chair Ron Wyden (D-Oregon) released a legislative proposal to address persistent economic problems leading to shortages of generic medicines plaguing America’s health care system, including chemotherapy drugs and ADHD medications.